Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Clinical trial NCT06280950 · RECRUITING
Trial details
- NCT number
- NCT06280950
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-12
- Primary completion
- 2028-06-30
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.